OR WAIT null SECS
October 07, 2020
Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.
The new personal capillary electrophoresis system, Spectrum Compact CE, performs Sanger sequencing and fragment analysis.
The company’s new CytoML Experiment Suite fully automates each stage of the flow cytometry data lifecycle, allowing for clearer data visualization and analysis.
October 06, 2020
Eudratec Fasteric is an oral drug delivery technology that offers enteric protection after rapid, homogeneous release for targeting the upper small intestine.
October 01, 2020
Sterling Pharma Solutions has acquired Alcami’s API facility in Germantown, WI.
Symbiosis has successfully completed a scheduled inspection by MHRA.
Optimus Holding has successfully completed the acquisition of OM Pharma.
Recipharm and BIAL have expanded their long-term supply agreement for the global manufacture and supply of opicapone API.
The technology is a novel, plasmid-free manufacturing system for robust and reproducible manufacture of AAV at scale.
The OneXpress solution is designed to accelerate oral dosage drug development and manufacturing.